QSQuintin P. Solano

Quintin P. Solano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Quintin P. Solano has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Dana A. Telem

    Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, MI

    4 shared publications
  • Justin Dimick

    Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, USA

    4 shared publications
  • Michael Englesbe

    Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, USA

    4 shared publications
  • Anne Ehlers

    Department of Surgery, University of Michigan, Ann Arbor, Michigan; Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, Michigan

    3 shared publications
  • Brian Fry

    Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, USA

    3 shared publications
  • Ryan Howard

    Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, USA

    3 shared publications

Latest Publications

  • Open Access

    Disseminated Chickenpox Following Live Varicella Vaccination in a Crohn’s Disease Patient on Combination Immunosuppression

    by Quintin Solano, Sarah Uttal, Peter D R Higgins, Jeffrey A Berinstein

    Novel therapeutics used in the treatment of inflammatory bowel disease pose an increased risk of viral reactivation in patients. We present a case of a patient with refractory Crohn’s disease (CD) who developed primary varicella (chickenpox) of a vaccine‐viral strain after receiving combination immunosuppression with high‐dose corticosteroids, tumor necrosis factor inhibitor (TNFi), and a Janus kinase inhibitor (JAKi) in the hospital. While this patient recovered and did not experience long term adverse effects, her case provides an opportunity for improvement. To improve safety, healthcare facilities should develop protocols that use electronic medical records enhanced with clinical decision support systems to identify and protect immunocompromised patients from inappropriate live vaccinations.


  • From Athlete to Surgeon: Examining Sports and Grit Among General Surgery Residents

    by Darci C. Foote, Darrell Tubbs, John N. Donkersloot, Bridger Rodoni, Samantha J. Baker, Quintin Solano, Niki Matusko, Julie A. Evans, Steven Gay, Erika Newman, et al.


  • The impact of frailty on ventral hernia repair outcomes in a statewide database

    by Quintin P. Solano, Ryan Howard, Cody L. Mullens, Anne P. Ehlers, Lia D Delaney, Brian Fry, Mary Shen, Michael Englesbe, Justin Dimick, Dana Telem

    Introduction Preoperative frailty is a strong predictor of postoperative morbidity in the general surgery population. Despite this, there are a paucity of research examining the effect of frailty on outcomes after ventral hernia repair (VHR), one of the most common abdominal operations in the USA. We examined the association of frailty with short-term postoperative outcomes while accounting for differences in preoperative, operative, and hernia characteristics. Methods We retrospectively reviewed the Michigan Surgery Quality Collaborative Hernia Registry (MSQC-HR) for adult patients who underwent VHR between January 2020 and January 2022. Patient frailty was assessed using the validated 5-factor modified frailty index (mFI5) and categorized as follows: no (mFI5 = 0), moderate (mFI5 = 1), and severe frailty (mFI5 ≥ 2). Our primary outcome was any 30-day complication. Multivariable logistic regression was used to evaluate the association of frailty with outcomes while controlling for patient, operative, and hernia variables. Results A total of 4406 patients underwent VHR with a mean age (SD) of 55 (15) years, 2015 (46%) females, and 3591 (82%) white patients. The mean (SD) BMI of the cohort was 33 (8) kg/m2. A total of 2077 (47%) patients had no frailty, 1604 (36%) were moderately frail, and 725 (17%) were severely frail. The median hernia size (interquartile range) was 2.5 cm (1.5–4.0 cm). Severe frailty was associated with increased odds of any complication (adjusted Odds Ratio (aOR) 3.12, 95% CI 1.78–5.47), serious complication (aOR 5.25, 95% CI 2.17–13.19), SSI (aOR 3.41, 95% CI 1.58–7.34), and post-discharge adverse events (aOR 1.70, 95% CI 1.24–2.33). Conclusion After controlling for patient, operative, and hernia characteristics, frailty was independently associated with increased odds of postoperative complications. These findings highlight the importance of preoperative frailty assessment for risk stratification and to inform patient counseling.


  • Application of Component Separation and Short-Term Outcomes in Ventral Hernia Repairs

    by Quintin P. Solano, Ryan Howard, Anne Ehlers, Lia D Delaney, Brian Fry, Michael Englesbe, Justin Dimick, Dana Telem


  • Variation of ventral and incisional hernia repairs in kidney transplant recipients

    by Quintin P. Solano, Jyothi R. Thumma, Cody Mullens, Ryan Howard, Anne Ehlers, Lia Delaney, Brian Fry, Mary Shen, Michael Englesbe, Justin Dimick, et al.

    Introduction As survivorship following kidney transplant continues to improve, so does the probability of intervening on common surgical conditions, such as ventral or incisional hernia, in this population. Ventral hernia management is known to vary across institutions and this variation has an impact on patient outcomes. We sought to evaluate hospital level variation of ventral or incisional hernia repair (VIHR) in the kidney transplant population. Methods We performed a retrospective review of 100% inpatient Medicare claims to identify patients who underwent kidney transplant between 2007 and 2018. The primary outcome was 1- and 3-year ventral or incisional risk- and reliability-adjusted VIHR rates. Patient and hospital characteristics were evaluated across risk- and reliability-adjusted VIHR rate tertiles. Models were adjusted for age, sex, race, and Elixhauser comorbidities. Results Overall, 139,741 patients underwent kidney transplant during the study period with a mean age (SD) of 51.6 (13.7) years. 84,717 (60.6%) were male, and 72,657 (52.0%) were white. Median follow up time was 5.4 years. 2098 (1.50%) patients underwent VIHR. the 1 year risk- and reliability-adjusted hernia repair rates were 0.49% (95% Conf idence Interval (CI) 0.48–0.51, range 0.31–0.59) in tertile 1, 0.63% (95% CI 0.62–0.63, range 0.59–0.68) in tertile 2, and 0.98 (95% CI 0.91–1.05, range 0.68–2.94) in tertile 3. Accordingly, compared to hospitals in tertile 1, the odds of post-transplant hernia repair tertile 2 hospitals were 1.78 (95% CI 1.37–2.31) and at tertile 3 hospitals 3.53 (95% CI 2.87–4.33). Conclusions In a large cohort of Medicare patients undergoing kidney transplant, the overall cumulative incidence of hernia repair varied substantially across hospital tertiles. Patient and hospital characteristics varied across tertile, most notably in diabetes and obesity. Future research is needed to understand if program and surgeon level factors are contributing to the observed variation in treatment of this common disease.


  • Leveraging a statewide quality collaborative to understand population-level hernia care

    by Ryan Howard, Anne Ehlers, Lia Delaney, Quintin Solano, Michael Englesbe, Justin Dimick, Dana Telem